402 related articles for article (PubMed ID: 15700025)
1. Urinary responses to acute moxonidine are inhibited by natriuretic peptide receptor antagonist.
El-Ayoubi R; Menaouar A; Gutkowska J; Mukaddam-Daher S
Br J Pharmacol; 2005 May; 145(1):50-6. PubMed ID: 15700025
[TBL] [Abstract][Full Text] [Related]
2. Atrial natriuretic peptide is involved in renal actions of moxonidine.
Mukaddam-Daher S; Gutkowska J
Hypertension; 2000 Jun; 35(6):1215-20. PubMed ID: 10856266
[TBL] [Abstract][Full Text] [Related]
3. Chronic imidazoline receptor activation in spontaneously hypertensive rats.
Menaouar A; El-Ayoubi R; Jankowski M; Gutkowska J; Mukaddam-Daher S
Am J Hypertens; 2002 Sep; 15(9):803-8. PubMed ID: 12219876
[TBL] [Abstract][Full Text] [Related]
4. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
Mukaddam-Daher S; Menaouar A; Gutkowska J
Eur J Pharmacol; 2006 Jul; 541(1-2):73-9. PubMed ID: 16774751
[TBL] [Abstract][Full Text] [Related]
5. The peripheral action of clonidine analog ST-91: involvement of atrial natriuretic factor.
Gutkowska J; Mukaddam-Daher S; Tremblay J
J Pharmacol Exp Ther; 1997 May; 281(2):670-6. PubMed ID: 9152372
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine.
Bock C; Niederhoffer N; Szabo B
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):262-71. PubMed ID: 10344524
[TBL] [Abstract][Full Text] [Related]
7. Clonidine and ST-91 may activate imidazoline binding sites in the heart to release atrial natriuretic peptide.
Mukaddam-Daher S; Lambert C; Gutkowska J
Hypertension; 1997 Jul; 30(1 Pt 1):83-7. PubMed ID: 9231825
[TBL] [Abstract][Full Text] [Related]
8. Imidazoline receptors in the heart: a novel target and a novel mechanism of action that involves atrial natriuretic peptides.
Mukaddam-Daher S; Gutkowska J
Braz J Med Biol Res; 2004 Aug; 37(8):1239-45. PubMed ID: 15273826
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy.
Cao C; Kang CW; Kim SZ; Kim SH
Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H150-6. PubMed ID: 14975931
[TBL] [Abstract][Full Text] [Related]
10. Involvement of central alpha1-adrenoceptors on renal responses to central moxonidine and alpha-methylnoradrenaline.
de Andrade CA; de Andrade GM; De Paula PM; De Luca LA; Menani JV
Eur J Pharmacol; 2009 Apr; 607(1-3):60-7. PubMed ID: 19326476
[TBL] [Abstract][Full Text] [Related]
11. Effects of moxonidine and clonidine on renal function and blood pressure in anesthetized rats.
Hohage H; Schlatter E; Greven J
Clin Nephrol; 1997 May; 47(5):316-24. PubMed ID: 9181279
[TBL] [Abstract][Full Text] [Related]
12. Neurohumoral mechanism in the natriuretic action of intracerebroventricular administration of renin.
Zavala L; Barbella Y; Israel A
J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):39-44. PubMed ID: 15136973
[TBL] [Abstract][Full Text] [Related]
13. Renal and blood pressure effects of moxonidine and clonidine in spontaneously hypertensive rats.
Hohage H; Hess K; Jahl C; Greven J; Schlatter E
Clin Nephrol; 1997 Dec; 48(6):346-52. PubMed ID: 9438092
[TBL] [Abstract][Full Text] [Related]
14. Moxonidine into the lateral parabrachial nucleus reduces renal and hormonal responses to cell dehydration.
Andrade CA; Margatho LO; Andrade-Franzé GM; De Luca LA; Antunes-Rodrigues J; Menani JV
Neuroscience; 2012 Apr; 208():69-78. PubMed ID: 22373877
[TBL] [Abstract][Full Text] [Related]
15. Atrial natriuretic peptide (ANP) inhibits its own secretion via ANP(A) receptors: altered effect in experimental hypertension.
Leskinen H; Vuolteenaho O; Toth M; Ruskoaho H
Endocrinology; 1997 May; 138(5):1893-902. PubMed ID: 9112384
[TBL] [Abstract][Full Text] [Related]
16. Imidazoline receptors but not alpha 2-adrenoceptors are regulated in spontaneously hypertensive rat heart by chronic moxonidine treatment.
El-Ayoubi R; Menaouar A; Gutkowska J; Mukaddam-Daher S
J Pharmacol Exp Ther; 2004 Aug; 310(2):446-51. PubMed ID: 15075383
[TBL] [Abstract][Full Text] [Related]
17. Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits.
Chan CK; Sannajust F; Head GA
J Pharmacol Exp Ther; 1996 Feb; 276(2):411-20. PubMed ID: 8632304
[TBL] [Abstract][Full Text] [Related]
18. Responsiveness of α2-adrenoceptor/I1-imidazoline receptor in the rostral ventrolateral medulla to cardiovascular regulation is enhanced in conscious spontaneously hypertensive rat.
Yamazato M; Nakamoto M; Sakima A; Yamazato Y; Takishita S; Ohya Y
Clin Exp Hypertens; 2019; 41(3):255-262. PubMed ID: 29764227
[TBL] [Abstract][Full Text] [Related]
19. Effects of moxonidine and clonidine on potassium excretion in Sprague-Dawley rats.
Hohage H; Mehrens T; Matzkies F; Steinmetz M; Greven J
Pharmacol Res; 1999 May; 39(5):357-61. PubMed ID: 10328993
[TBL] [Abstract][Full Text] [Related]
20. Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine.
Chan CK; Burke SL; Zhu H; Piletz JE; Head GA
Neuroscience; 2005; 132(4):991-1007. PubMed ID: 15857704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
